Beata Sperlagh - Publications

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Neuroscience Biology

113/159 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Huang L, Mut-Arbona P, Varga B, Török B, Brunner J, Arszovszki A, Iring A, Kisfali M, Vizi ES, Sperlágh B. P2X7 purinergic receptor modulates dentate gyrus excitatory neurotransmission and alleviates schizophrenia-like symptoms in mouse. Iscience. 26: 107560. PMID 37649698 DOI: 10.1016/j.isci.2023.107560  0.308
2023 Mut-Arbona P, Sperlágh B. P2 receptor-mediated signaling in the physiological and pathological brain: From development to aging and disease. Neuropharmacology. 233: 109541. PMID 37062423 DOI: 10.1016/j.neuropharm.2023.109541  0.301
2022 Al-Khrasani M, Karadi DA, Galambos AR, Sperlagh B, Vizi ES. The Pharmacological Effects of Phenylephrine are Indirect, Mediated by Noradrenaline Release from the Cytoplasm. Neurochemical Research. PMID 35945308 DOI: 10.1007/s11064-022-03681-2  0.305
2020 Diaz-Aparicio I, Paris I, Sierra-Torre V, Plaza-Zabala A, Rodríguez-Iglesias N, Márquez-Ropero M, Beccari S, Huguet P, Abiega O, Alberdi E, Matute C, Bernales I, Schulz A, Otrokocsi L, Sperlagh B, et al. Microglia actively remodel adult hippocampal neurogenesis through the phagocytosis secretome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31896673 DOI: 10.1523/Jneurosci.0993-19.2019  0.336
2020 Lakatos M, Baranyi M, Erőss L, Nardai S, Török TL, Sperlágh B, Vizi ES. Roles Played by the Na+/Ca2+ Exchanger and Hypothermia in the Prevention of Ischemia-Induced Carrier-Mediated Efflux of Catecholamines into the Extracellular Space: Implications for Stroke Therapy. Neurochemical Research. 45: 16-33. PMID 31346893 DOI: 10.1007/S11064-019-02842-0  0.433
2019 Tóth A, Antal Z, Bereczki D, Sperlágh B. Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration. Neurochemical Research. PMID 31054067 DOI: 10.1007/S11064-019-02798-1  0.328
2019 Huang L, Otrokocsi L, Sperlágh B. Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders. Brain Research Bulletin. PMID 30721770 DOI: 10.1016/J.Brainresbull.2019.01.030  0.388
2019 Horváth G, Otrokocsi L, Bekő K, Baranyi M, Kittel Á, Antonio Fritz-Ruenes P, Sperlágh B. P2X7 receptors drive poly(I:C) induced autism-like behavior in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30683682 DOI: 10.1523/Jneurosci.1895-18.2019  0.314
2018 Calovi S, Mut-Arbona P, Sperlágh B. Microglia and the Purinergic Signaling System. Neuroscience. PMID 30582977 DOI: 10.1016/J.Neuroscience.2018.12.021  0.429
2018 Balázsfi D, Zelena D, Demeter K, Miskolczi C, Varga ZK, Nagyváradi Á, Nyíri G, Cserép C, Baranyi M, Sperlágh B, Haller J. Differential Roles of the Two Raphe Nuclei in Amiable Social Behavior and Aggression - An Optogenetic Study. Frontiers in Behavioral Neuroscience. 12: 163. PMID 30116182 DOI: 10.3389/Fnbeh.2018.00163  0.369
2018 Kovács G, Környei Z, Tóth K, Baranyi M, Brunner J, Neubrandt M, Dénes Á, Sperlágh B. Modulation of P2X7 purinergic receptor activity by extracellular Zn in cultured mouse hippocampal astroglia. Cell Calcium. 75: 1-13. PMID 30098501 DOI: 10.1016/J.Ceca.2018.07.010  0.402
2018 Stephan G, Huang L, Tang Y, Vilotti S, Fabbretti E, Yu Y, Nörenberg W, Franke H, Göröncsér F, Sperlágh B, Dopychai A, Hausmann R, Schmalzing G, Rubini P, Illes P. The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel. Nature Communications. 9: 1354. PMID 29636447 DOI: 10.1038/S41467-018-03728-5  0.401
2017 Gölöncsér F, Baranyi M, Balázsfi D, Demeter K, Haller J, Freund TFF, Zelena D, Sperlágh B. Regulation of Hippocampal 5-HT Release by P2X7 Receptors in Response to Optogenetic Stimulation of Median Raphe Terminals of Mice. Frontiers in Molecular Neuroscience. 10: 325. PMID 29075178 DOI: 10.3389/Fnmol.2017.00325  0.458
2017 Beamer E, Kovács G, Sperlágh B. ATP released from astrocytes modulates action potential threshold and spontaneous excitatory postsynaptic currents in the neonatal rat prefrontal cortex. Brain Research Bulletin. PMID 29030320 DOI: 10.1016/J.Brainresbull.2017.10.006  0.35
2017 Otrokocsi L, Kittel Á, Sperlágh B. P2X7 Receptors Drive Spine Synapse Plasticity in the Learned Helplessness Model of Depression. The International Journal of Neuropsychopharmacology. 20: 813-822. PMID 28633291 DOI: 10.1093/Ijnp/Pyx046  0.307
2017 Bekő K, Koványi B, Gölöncsér F, Horváth G, Dénes Á, Környei Z, Botz B, Helyes Z, Müller CE, Sperlágh B. Contribution of platelet P2Y12 receptors to chronic Complete Freund's adjuvant-induced inflammatory pain. Journal of Thrombosis and Haemostasis. 15: 1223-1235. PMID 28345287 DOI: 10.1111/Jth.13684  0.38
2016 Koványi B, Csölle C, Calovi S, Hanuska A, Kató E, Köles L, Bhattacharya A, Haller J, Sperlágh B. The role of P2X7 receptors in a rodent PCP-induced schizophrenia model. Scientific Reports. 6: 36680. PMID 27824163 DOI: 10.1038/Srep36680  0.361
2016 Horváth T, Polony G, Fekete Á, Aller M, Halmos G, Lendvai B, Heinrich A, Sperlágh B, Vizi ES, Zelles T. ATP-Evoked Intracellular Ca(2+) Signaling of Different Supporting Cells in the Hearing Mouse Hemicochlea. Neurochemical Research. 41: 364-75. PMID 26801171 DOI: 10.1007/S11064-015-1818-4  0.338
2016 Beamer E, Gölöncsér F, Horváth G, Bekő K, Otrokocsi L, Koványi B, Sperlágh B. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior. Neuropharmacology. 104: 94-104. PMID 26384652 DOI: 10.1016/J.Neuropharm.2015.09.019  0.374
2016 Sperlagh B. Supra-Additive Impact Of Mitochondrial Dysfunction And Subsequent Oxidative Stress In Central Nervous System Pathology Journal of the International Society of Antioxidants in Nutrition & Health. 3. DOI: 10.18143/Jisanh_V3I2_1442  0.314
2015 Otrokocsi L, Gölöncsér F, Sperlágh B, Kittel Á. Learned helplessness paradigm in P2xr7 wild type and knock out mice and its effect on synapses in the dentate gyrus Springerplus. 4: 33. DOI: 10.1186/2193-1801-4-S1-P33  0.316
2015 Bekő K, Dénes Á, Horváth G, Sperlágh B. The effect of P2Y12 receptor inhibition in chronic inflammatory pain Springerplus. 4: 2. DOI: 10.1186/2193-1801-4-S1-P2  0.401
2015 Goloncser F, Ando R, Zelena D, Haller J, Sperlagh B. The effects of optical, electrical and chemical stimulation on serotonin release from median raphe and hippocampus of mice Springerplus. 4. DOI: 10.1186/2193-1801-4-S1-P14  0.376
2014 Sperlágh B, Illes P. P2X7 receptor: an emerging target in central nervous system diseases. Trends in Pharmacological Sciences. 35: 537-47. PMID 25223574 DOI: 10.1016/J.Tips.2014.08.002  0.313
2014 Horváth G, Gölöncsér F, Csölle C, Király K, Andó RD, Baranyi M, Koványi B, Máté Z, Hoffmann K, Algaier I, Baqi Y, Müller CE, Von Kügelgen I, Sperlágh B. Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiology of Disease. 70: 162-78. PMID 24971933 DOI: 10.1016/J.Nbd.2014.06.011  0.359
2014 Ficker C, Rozmer K, Kató E, Andó RD, Schumann L, Krügel U, Franke H, Sperlágh B, Riedel T, Illes P. Astrocyte-neuron interaction in the substantia gelatinosa of the spinal cord dorsal horn via P2X7 receptor-mediated release of glutamate and reactive oxygen species. Glia. 62: 1671-86. PMID 24895290 DOI: 10.1002/Glia.22707  0.465
2014 Gölöncsér F, Sperlágh B. Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine. The Journal of Headache and Pain. 15: 24. PMID 24885962 DOI: 10.1186/1129-2377-15-24  0.413
2013 Csölle C, Baranyi M, Zsilla G, Kittel A, Gölöncsér F, Illes P, Papp E, Vizi ES, Sperlágh B. Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors. Plos One. 8: e66547. PMID 23805233 DOI: 10.1371/Journal.Pone.0066547  0.444
2013 Andó RD, Sperlágh B. The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain. Brain Research Bulletin. 93: 80-5. PMID 23047057 DOI: 10.1016/J.Brainresbull.2012.09.016  0.485
2013 Csölle C, Andó RD, Kittel Á, Gölöncsér F, Baranyi M, Soproni K, Zelena D, Haller J, Németh T, Mócsai A, Sperlágh B. The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 213-33. PMID 22243662 DOI: 10.1017/S1461145711001933  0.355
2013 Baranyi M, Milusheva E, Sperlágh B. Neurochemical changes in animal models of Parkinson’s disease Molecular Neurodegeneration. 8: 7. DOI: 10.1186/1750-1326-8-S1-P7  0.431
2012 Sperlagh B, Csolle C, Ando RD, Goloncser F, Kittel A, Baranyi M. The role of purinergic signaling in depressive disorders. Neuropsychopharmacologia Hungarica : a Magyar PszichofarmakolóGiai EgyesüLet Lapja = Official Journal of the Hungarian Association of Psychopharmacology. 14: 231-8. PMID 23269209  0.364
2012 Richter H, Teixeira FM, Ferreira SG, Kittel Á, Köfalvi A, Sperlágh B. Presynaptic α₂-adrenoceptors control the inhibitory action of presynaptic CB₁ cannabinoid receptors on prefrontocortical norepinephrine release in the rat. Neuropharmacology. 63: 784-97. PMID 22722024 DOI: 10.1016/j.neuropharm.2012.06.003  0.388
2012 Heinrich A, Andó RD, Túri G, Rózsa B, Sperlágh B. K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study. British Journal of Pharmacology. 167: 1003-20. PMID 22394324 DOI: 10.1111/J.1476-5381.2012.01932.X  0.541
2012 Tautenhahn M, Leichsenring A, Servettini I, Pesic M, Sperlagh B, Nörenberg W, Illes P. Purinergic modulation of the excitatory synaptic input onto rat striatal neurons. Neuropharmacology. 62: 1756-66. PMID 22182780 DOI: 10.1016/J.Neuropharm.2011.12.001  0.545
2012 Andó RD, Bíró J, Csölle C, Ledent C, Sperlágh B. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus. Neurochemistry International. 60: 145-52. PMID 22133429 DOI: 10.1016/J.Neuint.2011.11.012  0.504
2012 Sperlagh B, Csolle C, Ando RD, Goloncser F, Kittel A, Baranyi M. A purinerg jelátviteli rendszer szerepe depressziós kórképekben New Phytologist. 14: 231-238. DOI: 10.5706/Nph201212003  0.399
2011 Ceruti S, Colombo L, Magni G, Viganò F, Boccazzi M, Deli MA, Sperlágh B, Abbracchio MP, Kittel A. Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochemistry International. 59: 259-71. PMID 21672581 DOI: 10.1016/J.Neuint.2011.05.013  0.334
2011 Hracskó Z, Baranyi M, Csölle C, Gölöncsér F, Madarász E, Kittel A, Sperlágh B. Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Molecular Neurodegeneration. 6: 28. PMID 21542899 DOI: 10.1186/1750-1326-6-28  0.37
2011 Sperlágh B, Vizi ES. The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Current Topics in Medicinal Chemistry. 11: 1034-46. PMID 21401497 DOI: 10.2174/156802611795347564  0.537
2011 Csölle C, Sperlágh B. Endocannabinergic modulation of interleukin-1β in mouse hippocampus under basal conditions and after in vivo systemic lipopolysaccharide stimulation. Neuroimmunomodulation. 18: 226-31. PMID 21389737 DOI: 10.1159/000323778  0.347
2011 Sperlágh B, Hracskó Z, Baranyi M, Csölle C, Gölöncsér F, Kittel Á, Madarász E. The double-faced role of P2X7 receptors in toxin-induced animal models of Parkinson’s disease Bmc Pharmacology. 11. DOI: 10.1186/1471-2210-11-S2-A56  0.417
2010 Milusheva E, Baranyi M, Kormos E, Hracskó Z, Sylvester Vizi E, Sperlágh B. The effect of antiparkinsonian drugs on oxidative stress induced pathological [3H]dopamine efflux after in vitro rotenone exposure in rat striatal slices. Neuropharmacology. 58: 816-25. PMID 19995567 DOI: 10.1016/J.Neuropharm.2009.11.017  0.343
2009 Sperlágh B, Windisch K, Andó RD, Sylvester Vizi E. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens. Neurochemistry International. 54: 452-7. PMID 19428788 DOI: 10.1016/J.Neuint.2009.01.017  0.471
2009 Rubini P, Milosevic J, Engelhardt J, Al-Khrasani M, Franke H, Heinrich A, Sperlagh B, Schwarz SC, Schwarz J, Nörenberg W, Illes P. Increase of intracellular Ca2+ by adenine and uracil nucleotides in human midbrain-derived neuronal progenitor cells Cell Calcium. 45: 485-498. PMID 19386359 DOI: 10.1016/J.Ceca.2009.03.008  0.467
2009 Valverde O, Célérier E, Baranyi M, Vanderhaeghen P, Maldonado R, Sperlagh B, Vassart G, Ledent C. GPR3 receptor, a novel actor in the emotional-like responses. Plos One. 4: e4704. PMID 19259266 DOI: 10.1371/Journal.Pone.0004704  0.358
2009 Csölle C, Andó RD, Baranyi M, Haller J, Sperlágh B. The role of P2X7 ATP receptors in the nervous system: potential implications in inflammatory and depression-like diseases Bmc Pharmacology. 9. DOI: 10.1186/1471-2210-9-S2-A53  0.373
2008 Milius D, Sperlagh B, Illes P. Up-regulation of P2X7 receptor-immunoreactivity by in vitro ischemia on the plasma membrane of cultured rat cortical neurons. Neuroscience Letters. 446: 45-50. PMID 18817842 DOI: 10.1016/J.Neulet.2008.09.023  0.419
2008 Csölle C, Heinrich A, Kittel A, Sperlágh B. P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices. Journal of Neurochemistry. 106: 347-60. PMID 18384646 DOI: 10.1111/J.1471-4159.2008.05391.X  0.553
2008 Heinrich A, Kittel A, Csölle C, Sylvester Vizi E, Sperlágh B. Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord. Neuropharmacology. 54: 375-86. PMID 18063000 DOI: 10.1016/J.Neuropharm.2007.10.013  0.526
2008 Milusheva E, Baranyi M, Kittel A, Fekete A, Zelles T, Vizi ES, Sperlágh B. Modulation of dopaminergic neurotransmission in rat striatum upon in vitro and in vivo diclofenac treatment. Journal of Neurochemistry. 105: 360-8. PMID 18036194 DOI: 10.1111/J.1471-4159.2007.05141.X  0.398
2008 Balázsa T, Bíró J, Gullai N, Ledent C, Sperlágh B. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus. Neurochemistry International. 52: 95-102. PMID 17719142 DOI: 10.1016/J.Neuint.2007.07.008  0.473
2007 Sperlágh B, Heinrich A, Csölle C. P2 receptor-mediated modulation of neurotransmitter release-an update. Purinergic Signalling. 3: 269-84. PMID 18404441 DOI: 10.1007/S11302-007-9080-0  0.521
2007 Sperlágh B, Illes P. Purinergic modulation of microglial cell activation. Purinergic Signalling. 3: 117-27. PMID 18404425 DOI: 10.1007/S11302-006-9043-X  0.412
2007 Wirkner K, Sperlagh B, Illes P. P2X3 receptor involvement in pain states. Molecular Neurobiology. 36: 165-83. PMID 17952660 DOI: 10.1007/S12035-007-0033-Y  0.34
2007 Sperlágh B, Zsilla G, Baranyi M, Illes P, Vizi ES. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience. 149: 99-111. PMID 17850981 DOI: 10.1016/J.Neuroscience.2007.07.035  0.575
2007 Sperlágh B, Vizi ES. Extracellular interconversion of nucleotides reveals an ecto-adenylate kinase activity in the rat hippocampus. Neurochemical Research. 32: 1978-89. PMID 17721817 DOI: 10.1007/S11064-007-9458-Y  0.453
2007 Milius D, Gröger-Arndt H, Stanchev D, Lange-Dohna C, Rossner S, Sperlagh B, Wirkner K, Illes P. Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells. Toxicology. 238: 60-9. PMID 17618031 DOI: 10.1016/J.Tox.2007.05.028  0.435
2007 Kittel A, Sperlágh B, Pelletier J, Sévigny J, Kirley TL. Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 25: 275-82. PMID 17576046 DOI: 10.1016/J.Ijdevneu.2007.05.007  0.317
2007 Papp L, Vizi ES, Sperlágh B. P2X7 receptor mediated phosphorylation of p38MAP kinase in the hippocampus. Biochemical and Biophysical Research Communications. 355: 568-74. PMID 17306762 DOI: 10.1016/J.Bbrc.2007.02.014  0.739
2007 Csölle C, Heinrich A, Sperlágh B. P2 receptor-mediated modulation of noradrenaline release by electrical field stimulation and ischemic conditions in superfused rat hippocampus slices Bmc Pharmacology. 7: 1-1. DOI: 10.1186/1471-2210-7-S2-A35  0.464
2007 Heinrich A, Vizi ES, Sperlágh B. New method for detecting ATP release from rat hippocampal slices Bmc Pharmacology. 7: A34. DOI: 10.1186/1471-2210-7-S2-A34  0.388
2006 Sperlágh B, Vizi ES, Wirkner K, Illes P. P2X7 receptors in the nervous system. Progress in Neurobiology. 78: 327-46. PMID 16697102 DOI: 10.1016/J.Pneurobio.2006.03.007  0.389
2006 Baranyi M, Milusheva E, Vizi ES, Sperlágh B. Chromatographic analysis of dopamine metabolism in a Parkinsonian model. Journal of Chromatography. A. 1120: 13-20. PMID 16580006 DOI: 10.1016/J.Chroma.2006.03.018  0.326
2005 Wirkner K, Köfalvi A, Fischer W, Günther A, Franke H, Gröger-Arndt H, Nörenberg W, Madarász E, Vizi ES, Schneider D, Sperlágh B, Illes P. Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. Journal of Neurochemistry. 95: 1421-37. PMID 16313518 DOI: 10.1111/J.1471-4159.2005.03465.X  0.511
2005 Milusheva EA, Kuneva VI, Itzev DE, Kortezova NI, Sperlagh B, Mizhorkova ZN. Glutamate stimulation of acetylcholine release from myenteric plexus is mediated by endogenous nitric oxide. Brain Research Bulletin. 66: 229-34. PMID 16023920 DOI: 10.1016/J.Brainresbull.2005.05.011  0.478
2005 Franke H, Klimke K, Brinckmann U, Grosche J, Francke M, Sperlagh B, Reichenbach A, Liebert UG, Illes P. P2X(7) receptor-mRNA and -protein in the mouse retina; changes during retinal degeneration in BALBCrds mice. Neurochemistry International. 47: 235-42. PMID 15964665 DOI: 10.1016/J.Neuint.2005.04.022  0.355
2005 Milusheva E, Baranyi M, Kittel A, Sperlágh B, Vizi ES. Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment. Free Radical Biology & Medicine. 39: 133-42. PMID 15925285 DOI: 10.1016/J.Freeradbiomed.2005.02.034  0.396
2005 Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2874-84. PMID 15772347 DOI: 10.1523/Jneurosci.4232-04.2005  0.541
2004 Papp L, Vizi ES, Sperlágh B. Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice. Neuroreport. 15: 2387-91. PMID 15640761 DOI: 10.1097/00001756-200410250-00017  0.747
2004 Kordás KS, Sperlágh B, Tihanyi T, Topa L, Steward MC, Varga G, Kittel A. ATP and ATPase secretion by exocrine pancreas in rat, guinea pig, and human. Pancreas. 29: 53-60. PMID 15211112 DOI: 10.1097/00006676-200407000-00056  0.371
2004 Sperlágh B, Baranyi M, Haskó G, Vizi ES. Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. Journal of Neuroimmunology. 151: 33-9. PMID 15145601 DOI: 10.1016/J.Jneuroim.2004.02.004  0.404
2004 Papp L, Balázsa T, Köfalvi A, Erdélyi F, Szabó G, Vizi ES, Sperlágh B. P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices. The Journal of Pharmacology and Experimental Therapeutics. 310: 973-80. PMID 15084650 DOI: 10.1124/Jpet.104.066712  0.747
2003 Németh ZH, Leibovich SJ, Deitch EA, Sperlágh B, Virág L, Vizi ES, Szabó C, Haskó G. Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. Biochemical and Biophysical Research Communications. 312: 883-8. PMID 14651954 DOI: 10.1016/J.Bbrc.2003.11.006  0.406
2003 Köfalvi A, Vizi ES, Ledent C, Sperlágh B. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. The European Journal of Neuroscience. 18: 1973-8. PMID 14622229 DOI: 10.1046/J.1460-9568.2003.02897.X  0.566
2003 Milusheva E, Sperlágh B, Shikova L, Baranyi M, Tretter L, Adám-Vizi V, Vizi ES. Non-synaptic release of [3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices. Neuroscience. 120: 771-81. PMID 12895517 DOI: 10.1016/S0306-4522(03)00340-3  0.457
2003 Sperlágh B, Szabó G, Erdélyi F, Baranyi M, Vizi ES. Homo- and heteroexchange of adenine nucleotides and nucleosides in rat hippocampal slices by the nucleoside transport system. British Journal of Pharmacology. 139: 623-33. PMID 12788822 DOI: 10.1038/Sj.Bjp.0705285  0.505
2003 Luthardt J, Borvendeg SJ, Sperlagh B, Poelchen W, Wirkner K, Illes P. P2Y(1) receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex. Neurochemistry International. 42: 161-72. PMID 12421596 DOI: 10.1016/S0197-0186(02)00069-4  0.364
2002 Brassai A, Makó K, Domjanschitz L, Sperlágh B. Lack of prejunctional modulation of noradrenaline release by endogenous nitric oxide in guinea pig pulmonary artery. Neurochemistry International. 41: 279-83. PMID 12106779 DOI: 10.1016/S0197-0186(02)00012-8  0.385
2002 Sperlágh B, Köfalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, Vizi ES. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. Journal of Neurochemistry. 81: 1196-211. PMID 12068068 DOI: 10.1046/J.1471-4159.2002.00920.X  0.553
2001 Sperlágh B, Illes P, Gerevich Z, Köfalvi A. Distinct Mechanisms Underlying α1-Adrenoceptor and P2x Purinoceptor Operated ATP Release and Contraction in the Guinea-Pig Vas Deferens Neurochemical Research. 26: 951-957. PMID 11699947 DOI: 10.1023/A:1012336601854  0.482
2001 Sperlágh B, Zsilla G, Vizi ES. KATP channel blockers selectively interact with A1-adenosine receptor mediated modulation of acetylcholine release in the rat hippocampus Brain Research. 889: 63-70. PMID 11166687 DOI: 10.1016/S0006-8993(00)03110-3  0.497
2001 Kordas K, Kittel A, Sperlagh B, Tihanyi T, Varga G. ATP and ATPase activity in pancreatic juice in rat, guinea-pig and man Gastroenterology. 120: A338. DOI: 10.1016/S0016-5085(08)81681-2  0.328
2001 Vizi ES, Haskó G, Lendvai B, Sperlágh B. Role of endogenous ATP in the regulation of pro- and antiinflammatory mediator production Drug Development Research. 53: 117-125. DOI: 10.1002/Ddr.1178  0.455
2000 Sperlágh B, Erdélyi F, Szabó G, Vizi ES. Local regulation of [ 3H]-noradrenaline release from the isolated guinea-pig right atrium by P 2X-receptors located on axon terminals British Journal of Pharmacology. 131: 1775-1783. PMID 11139458 DOI: 10.1038/Sj.Bjp.0703757  0.516
2000 Sperlágh B, Dóda M, Baranyi M, Haskó G. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. Journal of Neuroimmunology. 111: 45-54. PMID 11063820 DOI: 10.1016/S0165-5728(00)00365-9  0.454
2000 Katona I, Sperlágh B, Maglóczky Z, Sántha E, Köfalvi A, Czirják S, Mackie K, Vizi ES, Freund TF. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience. 100: 797-804. PMID 11036213 DOI: 10.1016/S0306-4522(00)00286-4  0.478
2000 Vizi ES, Nitahara K, Sato K, Sperlágh B. Stimulation-dependent release, breakdown, and action of endogenous ATP in mouse hemidiaphragm preparation: the possible role of ATP in neuromuscular transmission. Journal of the Autonomic Nervous System. 81: 278-284. PMID 10869732 DOI: 10.1016/S0165-1838(00)00129-6  0.505
1999 Vizi ES, Sperlagh B. Receptor- and carrier-mediated release of ATP of postsynaptic origin: Cascade transmission Progress in Brain Research. 120: 159-169. PMID 10550995 DOI: 10.1016/S0079-6123(08)63553-0  0.492
1999 Oe K, Sperlágh B, Sántha E, Matkó I, Nagashima H, Foldes FF, Vizi ES. Modulation of norepinephrine release by ATP-dependent K+-channel activators and inhibitors in guinea-pig and human isolated right atrium Cardiovascular Research. 43: 125-134. PMID 10536697 DOI: 10.1016/S0008-6363(99)00052-8  0.488
1999 Vizi ES, Sperlágh B. Separation of carrier mediated and vesicular release of GABA from rat brain slices Neurochemistry International. 34: 407-413. PMID 10397369 DOI: 10.1016/S0197-0186(99)00047-9  0.456
1999 Katona I, Sperlágh B, Sík A, Käfalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 4544-58. PMID 10341254 DOI: 10.1523/Jneurosci.19-11-04544.1999  0.491
1999 Jurányi Z, Sperlágh B, Vizi ES. Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices Brain Research. 823: 183-190. PMID 10095025 DOI: 10.1016/S0006-8993(99)01169-5  0.436
1999 Sperlágh B, Mergl Z, Jurányi Z, Vizi ES, Makara GB. Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis. Journal of Endocrinology. 160: 343-350. PMID 10076181 DOI: 10.1677/Joe.0.1600343  0.53
1998 Sperlágh B, Haskó G, Németh Z, Vizi ES. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochemistry International. 33: 209-15. PMID 9759915 DOI: 10.1016/S0197-0186(98)00025-4  0.327
1998 Sperlágh B, Maglóczky Z, Vizi ES, Freund TF. The triangular septal nucleus as the major source of ATP release in the rat habenula: a combined neurochemical and morphological study. Neuroscience. 86: 1195-207. PMID 9697126 DOI: 10.1016/S0306-4522(98)00026-8  0.449
1997 Sperlágh B, Sershen H, Lajtha A, Vizi ES. Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by α2-adrenoceptors Neuroscience. 82: 511-520. PMID 9466457 DOI: 10.1016/S0306-4522(97)00306-0  0.514
1997 Sperlágh B, Zsilla G, Baranyi M, Kékes-Szabó A, Vizi ES. Age-dependent changes of presynaptic neuromodulation via A1-adenosine receptors in rat hippocampal slices. International Journal of Developmental Neuroscience. 15: 739-747. PMID 9402224 DOI: 10.1016/S0736-5748(97)00028-2  0.486
1997 Sperlágh B, András I, Vizi ES. Effect of subtype-specific Ca2+-antagonists and Ca2+-free media on the field stimulation-evoked release of ATP and [3H]acetylcholine from rat habenula slices Neurochemical Research. 22: 967-975. PMID 9239752 DOI: 10.1023/A:1022470725132  0.457
1997 Vizi ES, Liang S-, Sperlágh B, Kittel Á, Jurányi Z. Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience. 79: 893-903. PMID 9219952 DOI: 10.1016/S0306-4522(96)00658-6  0.509
1997 Jurányi Z, Orsó E, Jánossy A, Szalay KS, Sperlágh B, Windisch K, Vinson GP, Vizi ES. ATP and [3H]noradrenaline release and the presence of ecto-Ca2+-ATPases in the capsule-glomerulosa fraction of the rat adrenal gland Journal of Endocrinology. 153: 105-114. PMID 9135575 DOI: 10.1677/Joe.0.1530105  0.527
1996 Sperlágh B, Vizi ES. Neuronal synthesis, storage and release of ATP Seminars in the Neurosciences. 8: 175-186. DOI: 10.1006/Smns.1996.0023  0.478
1995 Sperlágh B, Kittel Á, Lajtha A, Vizi ES. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzymecytochemical evidence Neuroscience. 66: 915-920. PMID 7651618 DOI: 10.1016/0306-4522(94)00588-V  0.457
1995 Sperlágh B, Jurányi Z, Vizi ES. Involvement of Ca2+ channels in the initiation of endogenous ATP release from rat habenula Pharmacological Research. 31: 201. DOI: 10.1016/1043-6618(95)87062-8  0.369
1992 Sperlágh B, Vizi ES. Is the neuronal ATP release from guinea-pig vas deferens subject to α2-adrenoceptor-mediated modulation? Neuroscience. 51: 203-209. PMID 1361216 DOI: 10.1016/0306-4522(92)90485-K  0.48
1992 Vizi ES, Sperlágh B, Baranyi M. Evidence that ATP, released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: Cascade transmission Neuroscience. 50: 455-465. PMID 1331864 DOI: 10.1016/0306-4522(92)90437-7  0.495
1992 Sperlágh B, Vizi ES. Differential modulation of neuronal ATP and [3H]noradrenaline release from guinea-pig vas deferens via alpha2-adrenoceptors Pharmacological Research. 25: 77-78. DOI: 10.1016/1043-6618(92)90295-M  0.403
1992 Nagano O, Földes FF, Nakatsuka H, Reich D, Ohta Y, Sperlagh B, Vizi ES. Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation. Naunyn-Schmiedebergs Archives of Pharmacology. 346: 197-202. DOI: 10.1007/Bf00167456  0.474
1991 Sperlagh B, Vizi ES. Effect of presynaptic P2 receptor stimulation on transmitter release Journal of Neurochemistry. 56: 1466-1470. PMID 1672880 DOI: 10.1111/J.1471-4159.1991.Tb02039.X  0.54
1990 Milusheva E, Sperlágh B, Kiss B, Szporny L, Pásztor E, Papasova M, Vizi ES. Inhibitory effect of hypoxic condition on acetylcholine release is partly due to the effect of adenosine released from the tissue. Brain Research Bulletin. 24: 369-373. PMID 2337817 DOI: 10.1016/0361-9230(90)90091-D  0.479
1990 Vizi ES, Sperlagh B, Lajtha A. Evidence for a Presynaptic P2X-Purinoceptor Involved in Facilitation of Acetylcholine Release Annals of the New York Academy of Sciences. 603: 500-502. DOI: 10.1111/J.1749-6632.1990.Tb37719.X  0.422
1990 Sperlagh B, Vizi ES. Stimulation of presynaptic P1 and P2 receptors at ATP in the auerbach's plexus European Journal of Pharmacology. 183: 1680. DOI: 10.1016/0014-2999(90)91974-G  0.314
1988 Sperlagh B, Vizi ES. Presynaptic modulation of the release of ATP and noradrenaline from rat vas deferens Pharmacological Research Communications. 20: 147-148. DOI: 10.1016/S0031-6989(88)80684-2  0.322
Low-probability matches (unlikely to be authored by this person)
2019 Cserép C, Pósfai B, Lénárt N, Fekete R, László ZI, Lele Z, Orsolits B, Molnár G, Heindl S, Schwarcz AD, Ujvári K, Környei Z, Tóth K, Szabadits E, Sperlágh B, et al. Microglia monitor and protect neuronal function via specialized somatic purinergic junctions. Science (New York, N.Y.). PMID 31831638 DOI: 10.1126/Science.Aax6752  0.294
2010 Csölle C, Sperlágh B. Peripheral origin of IL-1β production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X7 receptors Journal of Neuroimmunology. 219: 38-46. PMID 20022387 DOI: 10.1016/J.Jneuroim.2009.11.011  0.291
2017 Balázsfi DG, Zelena D, Farkas L, Demeter K, Barna I, Cserép C, Takács VT, Nyíri G, Gölöncsér F, Sperlágh B, Freund TF, Haller J. Median raphe region stimulation alone generates remote, but not recent fear memory traces. Plos One. 12: e0181264. PMID 28708877 DOI: 10.1371/Journal.Pone.0181264  0.29
2021 Román V, Kedves R, Kelemen K, Némethy Z, Sperlágh B, Lendvai B, Vizi ES. Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter-mediated nonquantal dopamine release. Physiological Reports. 9: e15088. PMID 34762352 DOI: 10.14814/phy2.15088  0.29
2017 Helyes Z, Kemény Á, Csekő K, Szoke E, Elekes K, Mester M, Sándor K, Perkecz A, Kereskai L, Mark L, Bona Á, Benkő A, Pintér E, Szolcsányi J, Ledent C, et al. Marijuana smoke induces severe pulmonary hyperresponsiveness, inflammation and emphysema in a predictive mouse model not via CB1 receptor activation. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00354.2016. PMID 28495855 DOI: 10.1152/Ajplung.00354.2016  0.287
2016 Baranyi M, Porceddu PF, Gölöncsér F, Kulcsár S, Otrokocsi L, Kittel Á, Pinna A, Frau L, Huleatt PB, Khoo ML, Chai CL, Dunkel P, Mátyus P, Morelli M, Sperlágh B. Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease. Molecular Neurodegeneration. 11: 6. PMID 26758813 DOI: 10.1186/S13024-015-0067-Y  0.285
2020 Calovi S, Mut-Arbona P, Tod P, Iring A, Nicke A, Mato S, Vizi ES, Tønnesen J, Sperlagh B. P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia. Frontiers in Molecular Neuroscience. 13: 566251. PMID 33262687 DOI: 10.3389/fnmol.2020.566251  0.276
2010 Ceruti S, Colombo L, Magni G, Viganò F, Gazdag Z, Boccazzi M, Sperlàgh B, Déli M, Abbracchio MP, Kittel Á. Role of the purinergic system in controlling blood-brain barrier functions upon ischemic conditions: focus on ATP-metabolizing enzymes Frontiers in Neuroscience. 4. DOI: 10.3389/Conf.Fnins.2010.10.00030  0.274
2018 Stephan G, Huang L, Tang Y, Vilotti S, Fabbretti E, Yu Y, Nörenberg W, Franke H, Gölöncsér F, Sperlágh B, Dopychai A, Hausmann R, Schmalzing G, Rubini P, Illes P. Author Correction: The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel. Nature Communications. 9: 3351. PMID 30120221 DOI: 10.1038/S41467-018-05621-7  0.271
2015 Huleatt PB, Khoo ML, Chua YY, Tan TW, Liew RS, Balogh B, Deme R, Gölöncsér F, Magyar K, Sheela DP, Ho HK, Sperlágh B, Mátyus P, Chai CL. Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease. Journal of Medicinal Chemistry. 58: 1400-19. PMID 25627172 DOI: 10.1021/Jm501722S  0.27
2005 Kittel A, Kiss AL, Müllner N, Matkó I, Sperlágh B. Expression of NTPDase1 and caveolins in human cardiovascular disease. Histochemistry and Cell Biology. 124: 51-9. PMID 16028070 DOI: 10.1007/S00418-005-0018-8  0.27
2008 Dunkel P, Gelain A, Barlocco D, Haider N, Gyires K, Sperlágh B, Magyar K, Maccioni E, Fadda A, Mátyus P. Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Current Medicinal Chemistry. 15: 1827-39. PMID 18691041 DOI: 10.2174/092986708785133022  0.269
2016 Illes P, Verkhratsky A, Burnstock G, Sperlagh B. Editorial purines in neurodegeneration and neuroregeneration. Neuropharmacology. PMID 26775822 DOI: 10.1016/J.Neuropharm.2016.01.020  0.268
2015 Horváth G, Otrokocsi L, Kittel Á, Baranyi M, Sperlágh B. Investigation of P2X7R involvement in maternal poly(i:C) exposure evoked autistic features in mice Springerplus. 4: 16. DOI: 10.1186/2193-1801-4-S1-P16  0.264
2023 Mut-Arbona P, Huang L, Baranyi M, Tod P, Iring A, Calzaferri F, de Los Ríos C, Sperlágh B. Dual Role of the P2X7 Receptor in Dendritic Outgrowth during Physiological and Pathological Brain Development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 43: 1125-1142. PMID 36732073 DOI: 10.1523/JNEUROSCI.0805-22.2022  0.26
2018 Fekete R, Cserép C, Lénárt N, Tóth K, Orsolits B, Martinecz B, Méhes E, Szabó B, Németh V, Gönci B, Sperlágh B, Boldogkői Z, Kittel Á, Baranyi M, Ferenczi S, et al. Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms. Acta Neuropathologica. PMID 30027450 DOI: 10.1007/S00401-018-1885-0  0.256
2010 Andó RD, Méhész B, Gyires K, Illes P, Sperlágh B. A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain. British Journal of Pharmacology. 159: 1106-17. PMID 20136836 DOI: 10.1111/j.1476-5381.2009.00596.x  0.248
2016 Aliczki M, Barna I, Till I, Baranyi M, Sperlagh B, Goldberg SR, Haller J. The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats. Psychopharmacology. PMID 26809457 DOI: 10.1007/S00213-016-4219-8  0.245
2016 Sódar BW, Kittel Á, Pálóczi K, Vukman KV, Osteikoetxea X, Szabó-Taylor K, Németh A, Sperlágh B, Baranyai T, Giricz Z, Wiener Z, Turiák L, Drahos L, Pállinger É, Vékey K, et al. Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Scientific Reports. 6: 24316. PMID 27087061 DOI: 10.1038/Srep24316  0.243
2017 Mohácsik P, Erdélyi F, Baranyi M, Botz B, Szabó G, Tóth M, Haltrich I, Helyes Z, Sperlágh B, Tóth Z, Sinkó R, Lechan RM, Bianco AC, Fekete C, Gereben B. A transgenic mouse model for detection of tissue-specific thyroid hormone action. Endocrinology. PMID 29253128 DOI: 10.1210/En.2017-00582  0.241
2022 Császár E, Lénárt N, Cserép C, Környei Z, Fekete R, Pósfai B, Balázsfi D, Hangya B, Schwarcz AD, Szabadits E, Szöllősi D, Szigeti K, Máthé D, West BL, Sviatkó K, et al. Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions. The Journal of Experimental Medicine. 219. PMID 35201268 DOI: 10.1084/jem.20211071  0.24
2012 Khansari PS, Sperlagh B. Inflammation in neurological and psychiatric diseases. Inflammopharmacology. 20: 103-7. PMID 22361843 DOI: 10.1007/S10787-012-0124-X  0.239
2021 Gölöncsér F, Baranyi M, Iring A, Hricisák L, Otrokocsi L, Benyó Z, Sperlágh B. Involvement of P2Y receptors in an NTG-induced model of migraine in male mice. British Journal of Pharmacology. PMID 34363208 DOI: 10.1111/bph.15641  0.229
2023 Iring-Varga B, Baranyi M, Gölöncsér F, Tod P, Sperlágh B. The antidepressant effect of short- and long-term zinc exposition is partly mediated by P2X7 receptors in male mice. Frontiers in Pharmacology. 14: 1241406. PMID 37908978 DOI: 10.3389/fphar.2023.1241406  0.22
2012 Dunkel P, Chai CL, Sperlágh B, Huleatt PB, Mátyus P. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis. Expert Opinion On Investigational Drugs. 21: 1267-308. PMID 22741814 DOI: 10.1517/13543784.2012.703178  0.214
2021 Iring A, Tóth A, Baranyi M, Otrokocsi L, Módis LV, Gölöncsér F, Varga B, Hortobágyi T, Bereczki D, Dénes Á, Sperlágh B. The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets. Pharmacological Research. 176: 106045. PMID 34968684 DOI: 10.1016/j.phrs.2021.106045  0.206
2019 Engel T, Sperlagh B. Purinergic signaling as a target for emerging neurotherapeutics. Brain Research Bulletin. PMID 31163189 DOI: 10.1016/J.Brainresbull.2019.05.022  0.189
2021 Huang L, Sperlágh B. Caffeine consumption and schizophrenia: A highlight on adenosine receptor-independent mechanisms. Current Opinion in Pharmacology. 61: 106-113. PMID 34688994 DOI: 10.1016/j.coph.2021.09.003  0.174
2011 Ando R, Goloncser F, Sperlagh B. Aetiology of depression International Clinical Psychopharmacology. 26. DOI: 10.1097/01.Yic.0000405654.86415.67  0.174
2021 Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy. 6: 162. PMID 33907179 DOI: 10.1038/s41392-021-00553-z  0.172
2022 Szabó D, Tod P, Gölöncsér F, Román V, Lendvai B, Otrokocsi L, Sperlágh B. Maternal P2X7 receptor inhibition prevents autism-like phenotype in male mouse offspring through the NLRP3-IL-1β pathway. Brain, Behavior, and Immunity. 101: 318-332. PMID 35065198 DOI: 10.1016/j.bbi.2022.01.015  0.162
2022 Huang L, Tang Y, Sperlagh B. Glial Purinergic Signaling-Mediated Oxidative Stress (GPOS) in Neuropsychiatric Disorders. Oxidative Medicine and Cellular Longevity. 2022: 1075440. PMID 35281471 DOI: 10.1155/2022/1075440  0.158
2022 Mut-Arbona P, Sperlágh B. Analysis of P2X7-Induced Neuronal Branching. Methods in Molecular Biology (Clifton, N.J.). 2510: 341-353. PMID 35776335 DOI: 10.1007/978-1-0716-2384-8_19  0.134
2015 Mano A, Barna I, Till I, Baranyi M, Sperlagh B, Haller J. P.1.h.004 The involvement of the medial prefrontal cortex and basolateral amygdala in the regulation of coping with stressors European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30335-7  0.13
2024 Gölöncsér F, Baranyi M, Tod P, Maácz F, Sperlágh B. P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1β. Iscience. 27: 109284. PMID 38444608 DOI: 10.1016/j.isci.2024.109284  0.12
2024 Iring A, Baranyi M, Iring-Varga B, Mut-Arbona P, Gál ZT, Nagy D, Hricisák L, Varga J, Benyó Z, Sperlágh B. Blood oxygen regulation via P2Y12R expressed in the carotid body. Respiratory Research. 25: 61. PMID 38281036 DOI: 10.1186/s12931-024-02680-x  0.12
2024 Tang Y, Rubini P, Sperlagh B, Ulrich H. Editorial: Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses. Frontiers in Pharmacology. 14: 1355286. PMID 38283840 DOI: 10.3389/fphar.2023.1355286  0.111
2023 Kristof Z, Gal Z, Torok D, Eszlari N, Sutori S, Erdelyi-Hamza B, Petschner P, Sperlagh B, Anderson IM, Deakin JFW, Bagdy G, Juhasz G, Gonda X. Variation along P2RX7 interacts with early traumas on severity of anxiety suggesting a role for neuroinflammation. Scientific Reports. 13: 7757. PMID 37173368 DOI: 10.1038/s41598-023-34781-w  0.089
2016 Aliczki M, Barna I, Till I, Baranyi M, Sperlagh B, Goldberg SR, Haller J. The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats Psychopharmacology. 1-11. DOI: 10.1007/s00213-016-4219-8  0.08
2024 Kristof Z, Gal Z, Torok D, Eszlari N, Sutori S, Sperlagh B, Anderson IM, Deakin B, Bagdy G, Juhasz G, Gonda X. Embers of the Past: Early Childhood Traumas Interact with Variation in Gene Implicated in Neuroinflammation on Markers of Current Suicide Risk. International Journal of Molecular Sciences. 25. PMID 38255938 DOI: 10.3390/ijms25020865  0.073
2021 Fazekas CL, Bellardie M, Török B, Sipos E, Tóth B, Baranyi M, Sperlágh B, Dobos-Kovács M, Chaillou E, Zelena D. Pharmacogenetic excitation of the median raphe region affects social and depressive-like behavior and core body temperature in male mice. Life Sciences. 286: 120037. PMID 34637795 DOI: 10.1016/j.lfs.2021.120037  0.068
2021 Kristof Z, Eszlari N, Sutori S, Gal Z, Torok D, Baksa D, Petschner P, Sperlagh B, Anderson IM, Deakin JFW, Juhasz G, Bagdy G, Gonda X. P2RX7 gene variation mediates the effect of childhood adversity and recent stress on the severity of depressive symptoms. Plos One. 16: e0252766. PMID 34111150 DOI: 10.1371/journal.pone.0252766  0.062
2021 Engel T, Nicke A, Deussing JM, Sperlagh B, Diaz-Hernandez M. Editorial: P2X7 as Common Therapeutic Target in Brain Diseases. Frontiers in Molecular Neuroscience. 14: 656011. PMID 33986644 DOI: 10.3389/fnmol.2021.656011  0.055
2016 Peiró AM, Planelles B, Juhasz G, Bagdy G, Libert F, Eschalier A, Busserolles J, Sperlagh B, Llerena A. Pharmacogenomics in pain treatment. Drug Metabolism and Personalized Therapy. 31: 131-42. PMID 27662648 DOI: 10.1515/dmpt-2016-0005  0.043
2022 Kristóf Z, Baranyi M, Tod P, Mut-Arbona P, Demeter K, Bitter I, Sperlágh B. Elevated serum purine levels in schizophrenia: a reverse translational study to identify novel inflammatory biomarkers. The International Journal of Neuropsychopharmacology. PMID 35443035 DOI: 10.1093/ijnp/pyac026  0.041
2019 Barra Caracciolo A, Patrolecco L, Grenni P, Di Lenola M, Ademollo N, Rauseo J, Rolando L, Spataro F, Plutzer J, Monostory K, Sperlagh B. Chemical mixtures and autochthonous microbial community in an urbanized stretch of the River Danube Microchemical Journal. 147: 985-994. DOI: 10.1016/J.MICROC.2019.04.021  0.01
Hide low-probability matches.